Status:
COMPLETED
Group Visits for High Risk Type 1 Diabetes (T1D)
Lead Sponsor:
Children's National Research Institute
Collaborating Sponsors:
American Diabetes Association
DexCom, Inc.
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D)...
Detailed Description
Dyads of youth with T1D aged 8-12 years and their primary diabetes caretakers identifying as non-Hispanic Black or Latinx will be recruited to participate in a pilot prospective cohort study exploring...
Eligibility Criteria
Inclusion
- Patients clinically diagnosed with T1D managed with insulin injections for at least 1 year
- Non-Hispanic Black or Latinx ethnicity
- Public healthcare insurance
- Male or female ages ≥ 8 and \< 12 years
- Poorly controlled T1D: one A1c value \> 8% in the preceding year
- Fluent in English as the Dexcom technology is currently available only in English
- Participation of the primary diabetes caregiver
Exclusion
- Use of insulin pump therapy for diabetes management at time of enrollment
- Major illnesses other than T1D
- Significant cognitive limitations and major psychiatric disorders in the child or
- Concurrent use of any non-insulin diabetes medication to control blood glucose levels.
- Concurrent participation in any other clinical studies during study period
Key Trial Info
Start Date :
February 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05431686
Start Date
February 16 2022
End Date
July 1 2025
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Hospital
Washington D.C., District of Columbia, United States, 20010